Welcome back to Stockhouse
Member Sign In

Email or Username:

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Enter your email address:
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Ventripoint Diagnostics Ltd V.VPT

Sector: Healthcare | Sub-Sector: Medical Instruments & Supplies
Alternate Symbol(s):  VPTDF

Ventripoint Diagnostics Ltd is a medical device company engaged in the development of diagnostic tools that monitor patients with heart disease.
Price: $0.065 | Change: $0.00 | %Change: 0.00%
Volume: 20,000 | Day High/Low: 0.065/0.065 | 52 Week High/Low: 0.165/0.025


Last Traded: September 29, 2014 05:51 Transaction Volume: 20,000
Open: $0.065 Previous Close: $0.065
Bid: $0.06 Ask: $0.07
Bid Size: 341,000 Ask Size: 40,000
Market Cap: $11.7m Shares Out: 179.9m
PE Ratio: 205.2 Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts


Canadian Biotech comes back to life: A buyer's guide

Everything you could ever want to know about biotech, biomed and bio investments up north.

Tony Pullen   January 21, 2014
0 stars

Ventripoint Diagnostics (V.NRT) down by over 40%

Stockhouse members have their say as we feature today’s Top Poster, Bullboard, and Blog, and recognize noteworthy contributions from our community.

Stockhouse Editorial   November 18, 2013
0 stars

Latest Bullboard Posts

  • bids thining out

    0 stars

    what's going on below 6c it's seems scary. No one is interested in 7c anymore

    1.5 stars

  • RE:RE:RE:RE:RE:re: CS post

    5 stars

    No, not lightening their load. The green means that they acquired shares (Ellen), or the right to purchase shares (Danny).  That is...

    2 stars

  • RE:RE:RE:RE:re: CS post

    0 stars

    Canadian Insider Report: Some easing up their load?? sr As of 11:59pm ET September 23rd, 2014 Filing Date Transaction Date Insider Name...

    4.5 stars

  • RE:RE:RE:re: CS post

    0 stars

    US is 40% of the world market according to the data on the other device I am getting FDA approval for.

    3.5 stars

  • RE:RE:re: CS post

    0 stars

    If Realcan is correct that there will be $5M in revenue in the first 12 months after CFDA approval and $20M thereafter... do we even care...

    2 stars